GLP-1 receptor agonists as adjunct therapy in type 1 diabetes are gaining attention as clinicians look for new ways to improve glycemic control
Effect of thiazolidinediones on body weight in patients with diabetes mellitus
In this study, researchers used a discovery approach to look for any associations they could find between GLP-1 receptor agonist drugs and 175 health outcomes
Weight-loss plateaus occur when our brain senses that were consuming fewer calories than normal and our fat stores are decreasing it slows down our metabolism Evolutionarily, were wired to protect fat to ensure survival So, weight-loss plateaus are a survival mechanism in the brain to try and protect us from starvation Fortunately, we can gradually lower our brains set point by continuing to lead a healthy lifestyle and being consistent in our habits Key points: Weight-loss plateaus are a necessary and normal part of the weight-loss process
found that GLP-1 receptor agonists (liraglutide, semaglutide, dulaglutide) significantly increased total testosterone and improved gonadotropin levels, especially in obese men
In vitro is a Latin phrase, in glass, that refers to research that is conducted outside of a living organism